Kintara Therapeutics to Present at the 2023 European Association for Neuro-Oncology Annual Meeting
SAN DIEGO, Sept. 5, 2023 /PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today
Source: eagletribune.com